About 270 results

ALLMedicine™ Anaplastic Oligodendroglioma Center

Research & Reviews  97 results

89ZrZr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
https://doi.org/10.1007/s00259-021-05543-5 10.1007/s00259-014-2830-7 10.1158/1078-0432.Ccr-15-0552 10.5858/arpa.2010-0740-OA 10.30699/ijp.2019.89854.1849 10.3389/fonc.2021.646387 10.1007/s00259-020-04715-z
European Journal of Nuclear Medicine and Molecular Imaging; Krebs S, Grommes C et. al.

Sep 10th, 2021 - 89ZrZr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.|2021|Krebs S,Grommes C,McDevitt MR,Carlin SD,O'Donoghue JA,|

A single institution retrospective analysis on survival based on treatment paradigms fo...
Journal of Neuro-oncology; Bush NAO, Young JS et. al.

Jun 15th, 2021 - Anaplastic oligodendrogliomas are high-grade gliomas defined molecularly by 1p19q co-deletion. There is no curative therapy, and standard of care includes surgical resection followed by radiation and chemotherapy. However, the benefit of up-front ...

TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas...
The Oncologist; Tabouret E, Fabbro M et. al.

Mar 31st, 2021 - Treatment with temozolomide and BCNU was associated with substantial response and survival rates for patients with unresectable anaplastic glioma, suggesting potential therapeutic alternative for these patients. The optimal treatment for unresecta...

Prolonged benefit to pembrolizumab in anaplastic oligodendroglioma patient with mismatc...
Anti-cancer Drugs; Padovan M, Caccese M et. al.

Jan 5th, 2021 - High-grade gliomas, including anaplastic oligodendroglioma, represent the most common malignant neoplasms of the central nervous system in the adult. The standard treatment of anaplastic oligodendroglioma consists of maximum surgical resection, ra...

Treatment of patients with glioma during the COVID-19 pandemic: what we learned and wha...
Neurosurgical Focus; Pessina F, Navarria P et. al.

Dec 2nd, 2020 - Coronavirus disease 2019 (COVID-19) has changed the way in which cancer is treated. Patients with high-grade glioma (HGG) are believed to be in a vulnerable category. The aim of this study was to describe the experience of a hub cancer center and ...

see more →

Guidelines  1 results

Central nervous system cancers.
Journal of the National Comprehensive Cancer Network : JN... Nabors LB, Ammirati M et. al.

Sep 14th, 2013 - Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemothera...

see more →

Clinicaltrials.gov  3 results

Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma

Jul 31st, 2018 - Background Glioblastoma (GBM) is the most common primary brain tumor. With optimal treatment, consisting of focal radiotherapy with concurrent chemotherapy, followed by adjuvant chemotherapy, median survival is 14.6 months. Most patients have evid...

LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma

Mar 14th, 2017 - Phase I Primary Objective • To determine the maximum tolerated dose (MTD) of LBH589 in combination with bevacizumab given at 10 mg/kg every 2 weeks in patients with recurrent glioblastoma (GBM), gliosarcoma, anaplastic astrocytoma, anaplastic olig...

Study of Capecitabine to Treat Recurrent High Grade Gliomas

Jul 2nd, 2013 - High grade gliomas (HGGs) represent a heterogenous group of primary brain tumors that share WHO grade III or IV classification (anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic mixed glioma, and glioblastoma multiforme). Despite th...

see more →

News  6 results

5 Abstracts Offer Snapshot of Immunology Research

Dec 5th, 2020 - The carcinoembryonic antigen (CEA) vaccinia has been researched for more than 20 years. Investigational Glioma Vaccine Results Promising A novel vaccine based on dendritic cells and peptides proved to be safe and capable of delivering an im...

Investigators Hope Glioma Trial of Eflornithine Will Clinch Approval

Dec 5th, 2020 - Victor A. Levin, MD Eflornithine (α-Difluoromethylornithine) has been investigated for over 30 years as a potential neuro-oncology agent and shown activity against recurrent gliomas, but it has not gained approval as a therapy option for patients...

Novel Combo Explored for Rare Brain Tumor

Dec 5th, 2020 - Victor A. Levin, MD Investigators are seeking to determine whether the combination of eflornithine (alphadifluoromethylornithine) with lomustine can improve survival for patients with recurrent anaplastic astrocytoma (AA). A rare form of brain tu...

Plenary Sunday at ASCO

Jul 26th, 2012 - Andrew L. Pecora, MD Editor-in-Chief Oncology & Biotech News Chief Innovations Officer, Professor, and Vice President of Cancer Services John Theurer Cancer Center at Hackensack University Medical Center I am sure any of us can think of many other...

Thunderclap Headache Associated With a Nonhemorrhagic Anaplastic Oligodendroglioma

Case Report A thunderclap headache is a severe headache with sudden onset similar to a clap of thunder, with a maximum intensity within 1 minute. The primary types (thunderclap, cough, exertional, and sexual) can recur intermittently and are gener...

see more →

Patient Education  1 results see all →